Literature DB >> 7400791

Analysis of verbal disability in Duchenne muscular dystrophy.

N J Karagan, L C Richman, J P Sorensen.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7400791     DOI： 10.1097/00005053-198007000-00005

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  9 in total

1.  Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of duchenne muscular dystrophy.

Authors:  V J Hinton; D C De Vivo; N E Nereo; E Goldstein; Y Stern
Journal:  J Int Neuropsychol Soc       Date:  2001-01       Impact factor: 2.892

2.  Poor verbal working memory across intellectual level in boys with Duchenne dystrophy.

Authors:  V J Hinton; D C De Vivo; N E Nereo; E Goldstein; Y Stern
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

3.  Altered Synaptic Transmission and Excitability of Cerebellar Nuclear Neurons in a Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Tabita Kreko-Pierce; Jason R Pugh
Journal:  Front Cell Neurosci       Date:  2022-07-05       Impact factor: 6.147

4.  Investigation of Poor Academic Achievement in Children with Duchenne Muscular Dystrophy.

Authors:  V J Hinton; D C De Vivo; R Fee; E Goldstein; Y Stern
Journal:  Learn Disabil Res Pract       Date:  2004-08

5.  Intellectual function in muscular dystrophies.

Authors:  T Glaub; F Mechler
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

6.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

7.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

8.  Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site.

Authors:  Maria Grazia D'Angelo; Maria Luisa Lorusso; Federica Civati; Giacomo Pietro Comi; Francesca Magri; Roberto Del Bo; Michela Guglieri; Massimo Molteni; Anna Carla Turconi; Nereo Bresolin
Journal:  Pediatr Neurol       Date:  2011-11       Impact factor: 3.372

9.  Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Wan-Chen Wu; Samual P Bradley; Jason M Christie; Jason R Pugh
Journal:  J Neurosci       Date:  2022-01-21       Impact factor: 6.709
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.